Nav: Home

Patrick Stiff, M.D., awarded Loyola's Stritch Medal

November 28, 2016

MAYWOOD, IL - Patrick J. Stiff, MD, a world renowned cancer physician, researcher and teacher, has received the Stritch Medal, the highest honor given by Loyola University Chicago Stritch School of Medicine.

Dr. Stiff, director of Loyola Medicine's Cardinal Bernardin Cancer Center, has developed groundbreaking new treatments for leukemia and lymphoma and built one of the largest and most successful bone marrow transplant programs in the world.

The Stritch Medal recognizes outstanding accomplishments of a Loyola graduate or faculty member who exhibits dedication to research, education, and patient care.

"I can't think of anyone who deserves it more," said J. Paul O'Keefe, MD, chair of Loyola's Department of Medicine.

Dr. Stiff received the Stritch Medal during the medical school's 66th annual Awards Dinner Nov. 19 at the Hilton Chicago. Since 1950, the dinner has raised millions of dollars for medical education scholarships for Stritch students. It's the longest-running black tie gala in Chicago.

"It is an incredible honor to receive the Stritch Medal this year," Dr. Stiff said. "While my name is on the medal, I wish to share this honor with my family, for without them this award would not have been possible. I also accept it on behalf of the faculty and staff of the Cardinal Bernardin Cancer Center who each day singly and collectively hold our patients and their families as their number one priority."

Dr. Stiff is the Coleman Professor of Oncology at Stritch and medical director of the Cardinal Bernardin Cancer Center at Loyola University Medical Center. Dr. Stiff also is co-director of Loyola's Oncology Research Institute and division director of Hematology/Oncology.

Dr. Stiff earned his medical degree from Stritch School of Medicine in 1975. (Dr. Stiff's father, Philip Stiff, MD, also is a Stritch alumnus.) Dr. Stiff completed a residency in internal medicine at Cleveland Clinic Foundation and a fellowship in hematology and medical oncology at Memorial Sloan Kettering Cancer Center.

Dr. Stiff returned to Loyola in 1986 to lead its bone marrow transplant program. Bone marrow transplants treat leukemia, lymphoma and other blood cancers. The patient undergoes high-dose chemotherapy and possibly whole-body radiation to kill the cancer cells. While wiping out the cancer, the treatments also kill the patient's immune system cells so the patient receives an infusion of bone marrow cells, which develop into healthy new immune system cells.

"At Loyola, we provide outstanding care that also calms and comforts, envelopes and empathizes, supports and sustains, is gracious and good-hearted, respectful and reassuring and especially is spiritual and sustaining," said Dr. Stiff.

During his fellowship, Dr. Stiff developed a method for cryopreserving bone marrow cells, which has been used in tens of thousands of transplants around the world. Dr. Stiff performed and reported the first blood stem cell transplants, which have become the standard method of transplantation for leukemias and lymphomas. He also developed new drugs with reduced side effects.

Dr. Stiff performed the first successful transplants involving bone marrow cells that were collected from the patient or donor and then grown in a lab. He also led the first successful international study of expanding the number of cells from donated umbilical cord blood, which is an alternative to bone marrow transplants.

Under Dr. Stiff's leadership, Loyola brought clinical research programs to 10 community hospitals in Chicago's west and south suburbs. He organized a cancer research collaboration with the University of Notre Dame and chaired the SWOG Bone Marrow and Stem Cell Transplantation Committee.

Innovative new therapies offered at Loyola have expanded the number of patients who are being cured with bone marrow patients. One such patient was among the youngest to ever receive a bone marrow transplant, a 10-month-old girl with refractory leukemia. Today she is a college student training to become a nurse. Older patients also have benefitted. While the traditional cutoff age for bone marrow transplants is 60, Loyola now offers the treatment to patients in their 60s and 70s.

"Dr. Stiff changed the standard of care around the world," said Kathy S. Albain, MD, professor in Loyola's Department of Medicine, Division of Hematology/Oncology. "His technologies and advances are applied every day to patients with leukemia and lymphoma. He has done all this while being an outstanding clinician and a great teacher and mentor."

Dr. Stiff has five children and provided medical foster care to 28 children. "His devotion to family extends to other families," said his daughter Stephanie Stiff, APN, an advanced practice nurse at Loyola.

Dr. Stiff also leads an adventuresome life outside of medicine. He climbed to the top of Mount Kilimanjaro, the tallest mountain in Africa, hiked in a scorching desert in Jordan, camped near the North Pole in minus 20 degrees, and once climbed to the base camp of Mount Everest. And at age 61, he walked to the bottom of the Grand Canyon and climbed back up to the top - in a single day.

"I've always had an interest in exploring and discovering," Dr. Stiff said.

Loyola University Health System

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at     You can read The Transition Integrity Project's report here.